Impact of drug resistance on clinical outcome in children with tuberculous meningitis

Pediatric Infectious Disease Journal

Volumn 31, Issue 7, 2012, Pages 711-716

  Seddon, James A ^a,b   Visser, Douwe H ^c   Bartens, Margaux ^c   Jordaan, Annemie M ^a   Victor, Thomas C ^a   Van Furth, A Marceline ^c   Schoeman, Johan F ^d   Schaaf, H Simon ^a,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Children; Meningitis; Outcome; Pediatric; Resistance; Tuberculosis

Indexed keywords

ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; TERIZIDONE;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CEREBROSPINAL FLUID; CHILD; DEATH; DISEASE SEVERITY; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOUS MENINGITIS;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL;

EID: 84862759558     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318253acf8     Document Type: Article

References (48)

1. Donald PR, Schoeman JF. Tuberculous meningitis. N Engl J Med. 2004;351:1719-1720. (Pubitemid 39383206)
2. Donald PR, Schaaf HS, Schoeman JF. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect. 2005;50:193-195. (Pubitemid 40361529)
3. Rich AR, McCordock HA. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp. 1933;52:5-37.
4. van Well GT, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics. 2009;123:e1-e8.
5. Lincoln EM. Tuberculous meningitis in children; with special reference to serous meningitis; tuberculous meningitis. Am Rev Tuberc. 1947;56:75-94.
6. Donald PR, Cotton MF, Hendricks MK, et al. Pediatric meningitis in the Western Cape Province of South Africa. J Trop Pediatr. 1996;42:256-261. (Pubitemid 26355960)
7. World Health Organization. Multidrug and Extensively Drug-resistant TB (M/XDR-TB) 2010 Global Report on Surveillance and Response 2010:(WHO/HTM/TB/ 2010.2013). Geneva, Switzerland: World Health Organization; 2010.
8. Marais BJ, Hesseling AC, Gie RP, et al. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis. 2006;42:e69-e71.
9. Schaaf HS, Shean K, Donald PR. Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child. 2003;88:1106-1111. (Pubitemid 38064490)
10. Drobac PC, Mukherjee JS, Joseph JK, et al. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006;117:2022-2029. (Pubitemid 46071247)
11. Patel VB, Padayatchi N, Bhigjee AI, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis. 2004;38:851-856. (Pubitemid 38387234)
12. Thwaites GE, Lan NT, Dung NH, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis. 2005;192:79-88. (Pubitemid 40863860)
13. Daikos GL, Cleary T, Rodriguez A, et al. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis. 2003;7:394-398. (Pubitemid 36433135)
14. Sofia M, Maniscalco M, Honoré N, et al. Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis. Int J Tuberc Lung Dis. 2001;5:551-558. (Pubitemid 32587286)
15. Thwaites G, Caws M, Chau TT, et al. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol. 2008;46:1363-1368. (Pubitemid 351563580)
16. Thwaites GE, Chau TT, Caws M, et al. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis. 2002;6:865-871. (Pubitemid 35190699)
17. Maree F, Hesseling AC, Schaaf HS, et al. Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis. Pediatr Infect Dis J. 2007;26:13-18. (Pubitemid 46045745)
18. Johnson R, Warren RM, van der Spuy GD, et al. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis. 2010;14:119-121.
19. Johnson R, Warren R, Strauss OJ, et al. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis. 2006;10:1412-1414. (Pubitemid 44924598)
20. Caws M, Thwaites G, Stepniewska K, et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol. 2006;44:3934-3939. (Pubitemid 44737232)
21. Health Systems Trust. Incidence of TB (all types) per 100,000. 2009. Available at: http://www.hst.org.za/sites/default/files/sahr10-21. Accessed April 18, 2012.
22. Schaaf HS, Marais BJ, Hesseling AC, et al. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa-an upward trend. Am J Public Health. 2009;99:1486-1490.
23. World Health Organization. Guidlelines for the Programmatic Management of Drug-resistant Tuberculosis-Emergency Update. WHO/HTM/TB/2008402. Geneva, Switzerland: World Health Organization; 2008.
24. Al-Dabbagh M, Lapphra K, McGloin R, et al. Drug-resistant tuberculosis: pediatric guidelines. Pediatr Infect Dis J. 2011;30:501-505.
25. Schaaf HS, Marais BJ. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Paediatr Respir Rev. 2011;12:31-38.
26. Warren RM, Gey van Pittius NC, Barnard M, et al. Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis. 2006;10:818-822. (Pubitemid 44031399)
27. Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177:787-792. (Pubitemid 351490566)
28. Warren RM, Streicher EM, Sampson SL, et al. Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. J Clin Microbiol. 2002;40:4457-4465. (Pubitemid 35434931)
29. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006;6:23.
30. Streicher EM, Victor TC, van der Spuy G, et al. Spoligotype signatures in the Mycobacterium tuberculosis complex. J Clin Microbiol. 2007;45:237-240. (Pubitemid 46106435)
31. World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-related Disease in Adults and Children. (ISBN: 978 92 4 159562 9). Geneva, Switzerland: World Health Organization; 2007.
32. Thwaites GE, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis. 2005;192:2134-2141. (Pubitemid 41779213)
33. Padayatchi N, Bamber S, Dawood H, et al. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J. 2006;25:147-150. (Pubitemid 43208569)
34. Hesseling AC, Marais BJ, Kirchner HL, et al. Mycobacterial genotype is associated with disease phenotype in children. Int J Tuberc Lung Dis. 2010;14:1252-1258.
35. Kong Y, Cave MD, Zhang L, et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J Clin Microbiol. 2007;45:409-414.
36. Marais BJ, Victor TC, Hesseling AC, et al. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol. 2006;44:3539-3543. (Pubitemid 46768796)
37. Nodieva A, Jansone I, Broka L, et al. Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2010;14:427-433.
38. Thwaites GE, Simmons CP, Than Ha Quyen N, et al. Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis. J Infect Dis. 2003;188:1105-1115. (Pubitemid 37338973)
39. Donald PR, Schoeman JF, Van Zyl LE, et al. Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis. 1998;2:704-711. (Pubitemid 28429719)
40. World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. WHO/HTM/TB/2006371, WHO/FCH/CAH/20067. Geneva, Switzerland: World Health Organization; 2006.
41. World Health Organization. Rapid Advice. Treatment of Tuberculosis in Children. WHO/HTM/TB/201013. Geneva, Switzerland: World Health Organization; 2010.
42. Donald PR. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (Edinb). 2010;90:279-292.
43. Hoek KG, Schaaf HS, Gey van Pittius NC, et al. Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. S Afr Med J. 2009;99:785-787.
44. Schaaf HS, Victor TC, Venter A, et al. Ethionamide cross-and co-resistance in children with isoniazid-resistant tuberculosis. Int J Tuberc Lung Dis. 2009;13:1355-1359.
45. Schaaf HS, Victor TC, Engelke E, et al. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children. Eur J Clin Microbiol Infect Dis. 2007;26:203-205.
46. Müller B, Streicher EM, Hoek KG, et al. inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int J Tuberc Lung Dis. 2011;15:344-351.
47. Sneag DB, Schaaf HS, Cotton MF, et al. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J. 2007;26:1142-1146. (Pubitemid 350190948)
48. Seddon JA, Godfrey-Faussett P, Hesseling AC, et al. Management of children exposed to multidrug-resistant Mycobacterium tuberculosis. Lancet Infect Dis. 2012;12:469-479.